OMX30 1 520 1,1%  OMXH25 3 587 0,5%  OMXC20 839 0,6%  Dow 19 630 0,4%  Nas 4 858 0,1%  EUR 9,7054 -0,5%  USD 9,1426 0,8%  Olja 53,9 0,9%  Guld 1 171 -0,2% 

Baxter International Aktie

44,03USD -0,09USD -0,20%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Baxter International

2015 2016e 2017e 2018e 2019e
Utdelning 0,71 0,52 0,61 0,67 0,69
Direktavkastning (i %) 1,86 1,14 1,35 1,48 1,52
PE-tal 27,68 23,86 21,27 18,37 16,72
Resultat/aktie 1,38 1,91 2,14 2,48 2,72

Nyheter om Baxter International Inc.

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om Baxter International Inc.

ytterligare analyser

Baxter International Peer Group

Baxter International 44,03
-0,2%
Boston Scientific 20,61
0,0%
Cardinal Health 71,13
0,9%
Fresenius Medical Care 74,87
1,2%
Fresenius 68,56
1,0%
Medtronic 71,96
-0,3%
STRATEC Biomedical 42,50
0,7%
pagehit

Inloggning krävs

Användarnamn (e-post):
Lösenord:
Logga in

För att använda myFinans funktioner måste du vara inloggad. Om du inte har något användarkonto hos VA Finans kan du registrera dig här utan kostnad.

Lägg till instrument

Vad tycker du?

Profil Baxter International Inc.

till bolagsprofilen
Baxter International, Inc. provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctor's offices and by patients at home under physician supervision. It operates through the following segments: Hospital Products and Renal. The Hospital Products segment intravenous IV solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation. The Renal segment provides products and services to treat end-stage renal disease, or irreversible kidney failure and acute kidney injuries. This segment offers a comprehensive portfolio to meet the needs of patients across the treatment continuum, including technologies and therapies for peritoneal dialysis, in-center hemodialysis, home HD, continuous renal replacement therapy and additional dialysis services. Baxter International was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Realtidskurs Baxter International Inc.

Bid
44,02
USD
Ask
44,05
USD
Kurstid
19:26
Börsen BTT

Aktiekurs Baxter International Inc. i USDPUSH CHART

Kurs 44,03 USD -0,09 -0,20 %
Kurstid 19:26:12
Datum 08.12.2016
Öppning 43,97
Gårdagen 44,12
Dagshögsta 44,20
Dagslägsta 43,82
52 v. högsta 50,15
52 v. lägsta 34,07
52 v. perf.
Volym (Antal) 77 590
Börsvärde (SEK) 216,13 Mrd
Börsen
Kurs för 44,03 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 402,55 SEK.

Till aktien Baxter International

Ticker
ISIN US0718131099
Index S&P 500, S&P 100, NYSE US 100, BX Swiss - USA

Baxter International Nyckeltal

Börsvärde i SEK 216,13 Mrd
Free float % 99,69
Antal aktier mio. 543,92
Cashflow/aktie i lokal valuta 2,33
Bokvärde/aktie i lokal valuta 15,70
60 dagar vola 31,32
PBV 2,43

Baxter International Historiska kurser

2016-12-07 44,12 354 468
2016-12-06 43,99 199 040
2016-12-05 43,89 367 130
2016-12-02 44,02 323 887
2016-12-01 43,62 465 440